Understanding the detailed mechanisms mediating insulin signal transduction
has been viewed as a critical step in the development of therapeutic appli
cations to ameliorate diabetes and its attendant complications. One critica
l element in the insulin-signalling pathway is the insulin receptor. The in
sulin receptor is a heterotetrameric transmembrane protein that binds insul
in on the surface of cells and transduces insulin signals through the plasm
a membrane to the cytoplasm. With the cloning of the gene for the insulin r
eceptor it became possible to efficiently manipulate receptor and identify
sequences that are crucial to its function. In turn, these analyses have un
covered potential therapeutic approaches to enhance receptor function. The
patents covered:by this review date from 1988 to 1999.